User:Mr. Ibrahem/Temozolomide

Temozolomide (TMZ), sold under the brand name Temodar among others, is a medication used to treat brain tumors such as glioblastoma and anaplastic astrocytoma. It is taken by mouth or by gradual injection into a vein.

Common side include nausea, vomiting, constipation, loss of appetite, hair loss, headache, tiredness, seizures, rash, low white blood cells, and low platelet. People receiving the injection may also have pain, irritation, itching, redness, or bruising at the site. Other side effects may include Pneumocystis jiroveci pneumonia, other cancers, and hepatitis B reactivation. It is an alkylating agent.

Temozolomide was approved for medical use in the United States and Europe in 1999. It is available as a generic medication. In the United Kingdom five pills of 250 mg costs the NHS about £530 as of 2021. This amount in the United States costs about 135 USD.